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Abstract
Chikungunya virus (CHIKV) is a worldwide emerging pathogen. In humans it causes a syndrome characterized by high fever,
polyarthritis, and in some cases lethal encephalitis. Growing evidence indicates that the innate immune response plays a
role in controlling CHIKV infection. We show here that CHIKV induces major but transient modifications in NK-cell
phenotype and function soon after the onset of acute infection. We report a transient clonal expansion of NK cells that
coexpress CD94/NKG2C and inhibitory receptors for HLA-C1 alleles and are correlated with the viral load. Functional tests
reveal cytolytic capacity driven by NK cells in the absence of exogenous signals and severely impaired IFN-c production.
Collectively these data provide insight into the role of this unique subset of NK cells in controlling CHIKV infection by
subset-specific expansion in response to acute infection, followed by a contraction phase after viral clearance.
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Introduction
Emerging and re-emerging viral infectious diseases can cause
devastating illnesses in humans and are accordingly one of the
principal challenges in global health care today. Among these
viruses, arthropod-borne arboviruses are especially important
because many of them cause fatal diseases in humans and animals
[1,2]. Chikungunya virus (CHIKV) is an Aedes mosquito-borne
alphavirus from the Togaviridae family. Typically, a silent
incubation period of 2–4 days usually follows infection by
CHIKV, and symptoms arise afterwards. CHIKV-associated
disease is an acute illness characterized by fever, skin rash, and
severe incapacitating arthralgia [2–4]. Most clinical symptoms of
CHIKV infection generally resolve within a few weeks, except for
joint stiffness and pain, the hallmark of chronic CHIKV infection,
which can persist for months or years. Intriguingly, CHIKV,
which has historically been transmitted by Aedes aegypti mosquitoes,
has repeatedly been associated in recent years with a new vector,
Aedes albopictus, which has spread into tropical areas and dispersed
worldwide [5]. CHIKV has been identified in nearly 40 countries
and is currently present in Asia, the United States, Central Africa
and Europe; the US National Institute of Allergy and Infectious
Disease (NIAID) listed it as a category C priority pathogen in 2008
[2,6,7]. These recent outbreaks have resulted in more detailed
descriptions of its clinical manifestations, including complications
such as maternal-fetal transmission and fatal hemorrhagic and
neurologic manifestations [8,9].
Although much is known about this disease, the study of
immune response to CHIKV infection is in its infancy. Reports in
humans and in a macaque model show that virus elimination
occurs very rapidly, before the host can mount IgG and T cell
responses and thus suggest an effective innate immune response.
Type-1 interferon (IFN) has been detected at high levels in the
serum of infected individuals, its concentration correlated with
viral load [10–14]. Natural killer (NK) cells are also an important
mediator of the innate immune defense during early infectious
events. NK cells mediate their antiviral effects through at least
three different mechanisms: (1) the release of immunoregulatory
cytokines, particularly IFN-c, which enhance the innate immune
response and help to shape the subsequent adaptive immune
response, (2) the production of cytolytic granules for lysis of
infected cells, and (3) the induction of target-cell death through cell
surface receptors [15,16].
The variety of signaling pathways to stimulate NK cells equips
these cells with multiple detection systems for sensing and
responding to infection and thus makes it more difficult for
viruses to escape detection and defense. NK-cell function is
controlled by the integration of signals from various activating and
inhibitory cell surface receptors [17–19]. Its direct cytolytic activity
is associated with downregulation of major histocompatibility
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inhibitory receptors have been identified, including the killer cell
immunoglobulin (Ig)-like receptor (KIR) family, CD94/NK2A,
and ILT-2. These inhibitory receptors recognize self-molecules
constitutively expressed on host cells. NK cells, however, are only
activated when activating receptors, including NKG2C, NKG2D,
DNAM-1, and the natural cytotoxicity receptors (NKp30, NKp44
and NKp46), are triggered on NK cells at the same time that
inhibitory receptors engage. NK functions are therefore finely
tuned by crosstalk between the expression of activating and
inhibitory receptors, and NK cells serve as important sentinels of
the immune system, working as first responders and alerting the
host of the presence of infectious organisms [18,19].
Different studies have demonstrated the importance of NK cells
in controlling human viral infections, such as EBV, CMV, and
HSV [20]. Nonetheless, the involvement of these cells in response
to alphaviruses has not been characterized either thoroughly or
consistently. For example, the in vitro culture of Ross River virus
was reported to result in enhanced rather than depressed NK cell
activity [21]. More recently, Alsharifi et al. [22] demonstrated that
NK cells without marked cytotoxic T cell involvement control the
acute virulent Semliki Forest virus infection of the central nervous
system in C57BL/6J mice. The frequency and activation rate of
NK cells increase during acute CHIKV infection [23]. In another
arboviral infection, Azeredo et al. [24] observed that most NK cells
from dengue-infected patients display early activation markers and
cell adhesion molecules during the acute phase of the disease.
More recently, Hershkovitz et al. [25] showed that interaction of
the NKp44 activating NK receptor with the flavivirus envelope
protein mediates the triggering of NK cells in both West Nile and
dengue viruses. Intriguingly, several flaviviruses may attenuate NK
cell cytotoxicity by increasing cell surface expression of MHC
class-I molecules to overcome susceptibility to NK cell mediated
lysis [26,27].
The aim of this study was to conduct a detailed phenotypic and
functional analysis of NK cells during acute infection by this
emerging disease, to characterize the role of NK cells during
CHIKV infection. Our data, collected at a very early point post-
infection, showed engagement of a clonal expansion of CD94/
NKG2C
+ NK cells that expressed receptors for HLA-C1 alleles.
We describe their functional features.
Results
Changesintheproportionandactivationstatusofdifferent
lymphocytic subsets from CHIKV-infected patients




+ NK subsets in CHIKV-infected patients as well as in
healthy Caucasian and Gabonese individuals. These lymphocyte
subsets were found at similar frequencies in both healthy control
groups, regardless of their origin. In contrast, and consistently with
previous studies [14,23], the percentage of CD3
+ T cells was
significantly lower in CHIKV-infected patients (p,0.0001) than in
controls (Figure 1A). Infection-associated profound T lymphope-
nia tended to spare CD3
-CD56
+ NK cells, and the proportions of
these cells increased significantly after CHIKV infection, to
13.063.9% compared with 8.464.3% in healthy Gabonese
controls (p=0.0006) (Figure 1A). The increase in NK-cell
frequency was directly correlated with viral load (r=0.7337;
p=0.0005) (Figure 1B). However, the absolute count of NK cells
from the Caucasian CHIKV-infected patients (233648 per mm
3)
was similar to that among the healthy Caucasian controls (275666
per mm
3). In contrast, the CD3
+ T cell count was sharply lower in
CHIKV-infected patients than in controls (Supplementary Table
S1). These data are in line with a previous published study [23]. Of




+ NK cells was transient and rapidly returned to
baseline levels after a two month-period (Figure 1C).
NK cells can be divided into CD56
bright and CD56
dim popula-
tions, based on the cell-surface density of the CD56 molecules;
these subgroups present distinct phenotypic and functional
properties [28]. Intriguingly, the percentage of CD56
bright NK
cells was very significantly lower in CHIKV-infected patients than
in healthy controls (p,0.0001) (Figure 1D), a finding that supports
the hypothesis of profound upheavals of the NK cell subset after
CHIKV infection.
The percentage of activated NK cells was also assessed by flow
cytometric determination of the early activation marker CD69. As
shown in Figure 1E, the NK cells from CHIKV-infected patients
were activated; 77.269.9% of the NK cells expressed CD69 vs
15.466.2% in healthy donors (p,0.0001). Similar results were
observed with HLA-DR, another activation marker (Figure 1E).
Furthermore, within two months, the rate of NK cell activation
reverted back to that of healthy donors (Figure 1F), in association
with viral clearance (Supplementary Table S1).
Major phenotypic features of NK cells from CHIKV-
infected patients
To explore whether CHIKV infection was associated with the
pattern of natural killer receptor (NKR) expression, flow
cytometric analysis was performed with anti-CD3 and anti-
CD56 mAbs, in combination with a panel of reagents for NKR.
CHIKV-infected and healthy individuals did not differ signifi-
cantly in their proportions of NK cells bearing NKG2D, 2B4,
LAIR-1, and DNAM-1 (data not shown). In contrast, both the
frequency of fluorescence intensity and mean fluorescence
intensity (MFI) of NKp30 and NKp46, two specific natural cyto-
toxic receptors (NCR) constitutively expressed on virtually all NK
cells, decreased significantly after CHIKV-infection (Figure 2A
and Supplementary Figure S1). In contrast, NKp44, a marker
usually expressed only upon activation, was upregulated in most
infected patients, as were other CD69 and HLA-DR activation
markers (Figures 1E and 2A). More importantly, the balance of
inhibitory NKG2A to activating NKG2C cells switched during
acute CHIKV infection. Thus, all infected patients showed a
significant loss of both the frequency (p,0.0001) and MFI
Author Summary
Chikungunya virus (CHIKV) infection, which is responsible
for devastating human illness, is rapidly becoming a global
concern. The spread of this disease throughout tropical
areas, where it now affects nearly 40 countries, underlines
the need to improve our understanding of this infection. In
2008, CHIKV was listed as a US National Institute of Allergy
and Infectious Disease (NIAID) category C priority patho-
gen. Natural killer (NK) cells are cytotoxic effector cells that
play a vital role in the innate immune system by limiting
acute infection, as previously described for several other
diseases. This report describes the first phenotypic and
functional analysis of NK cells soon after infection by this
virus. The key element of this study was the detailed
analysis of the expansion of NK cells. Coexpression of
NKG2C activating receptors and HLA-C1 ligands is
associated with viral load, impaired IFN-c production,
and significant cytolytic functions. We found that NK cells
were able to sense CHIKV from the beginning of infection
and contributed to the clearance of the infected cells
through the expansion of a unique NK-cell subset.
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PLoS Pathogens | www.plospathogens.org 2 September 2011 | Volume 7 | Issue 9 | e1002268Figure 1. Distribution and activation status of NK cells from CHIKV-infected patients. (A) FACS analysis of percentages of CD3
+ T cells and
CD3
-CD56
+ NK cells from 15 Caucasian (CAU) and 15 Gabonese (GAB) healthy donors, and 25 CHIKV-infected patients (CHIK). Samples were gated on
the lymphocyte gate for flow cytometric analysis. Horizontal bars represent the median values. Representative samples of each group are presented
in the lower panels. Numbers are the percentage of CD3
-CD56
+ NK cells in the CD45
+ lymphocyte gate. The region used to determine the proportion
of CD3
-CD56
+ NK cells is shown. (B) Correlation between viral load and frequency of NK cells from CHIKV-infected patients. (C) Longitudinal studies of
the percentage of CD3
-CD56
+ NK cells from 3 Caucasian CHIK-infected patients. (D) Frequency of CD56
bright cells among the CD3
-CD56
+ NK cells. (E)
Expression of the activation markers CD69 or HLA-DR on NK cells. Samples were gated on the CD3
-CD56
+ NK-cell subset for flow cytometric analysis.
Horizontal bars indicate the median. Representative samples of each group are presented in the lower panels. Numbers are the percentage of CD69
+
cells in the CD3
-CD56
+ NK-cell gate. (F) Longitudinal study of the percentage of CD3
-CD56
+ NK cells expressing CD69, from 3 CHIKV-infected
Caucasian patients. **: p,0.001; ***: p,0.0001.
doi:10.1371/journal.ppat.1002268.g001
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PLoS Pathogens | www.plospathogens.org 3 September 2011 | Volume 7 | Issue 9 | e1002268Figure 2. Patterns of specific NK receptors on CD3
-CD56
+ NK cells from CHIKV-infected patients. PBMC were collected from 15
Caucasian (CAU) and 15 Gabonese (GAB) healthy donors, and 25 CHIKV-infected patients (CHIK) to perform large-scale five-color flow cytometric
analysis of CD3
-CD56
+ NK cells. (A) Frequency of the expression of NK-cell receptors including: NCR (NKp30, NKp44 and NKp46), NKG2A and NKG2C,
ILT-2, as well as CD161, CD57, and CD8a. Horizontal bars indicate the median. *: p,0.05; **: p,0.001; ***: p,0.0001. (B) Hierarchical clustering of the
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+ NK cells, a loss corresponding to the
dramatic expansion of NK cells expressing NKG2C activating
receptors. The percentage of NKG2C
+ cells increased after
CHIKV infection, to 46.6622.3% compared with 9.364.3% in
healthy Gabonese controls (p,0.0001) (Figure 2A and Supple-
mentary Figure S1A). Similarly, MFI of NKG2C increased
significantly in CHIKV-infected patients, compared with controls
(Supplementary Figure S1B). In addition, both the percentage and
the MFI of NK cells expressing ILT-2, an inhibitory receptor that
recognizes a broad range of classical MHC class-I molecules on
surrounding cells, were higher in CHIKV-infected patients than
controls. Specifically, around 77% of the NK cells from infected
patients expressed ILT-2, compared with 53% of those from
Gabonese and 38% from Caucasian healthy controls (Figure 2A
and Supplementary Figure S1). This difference suggests an
important expansion of a distinct population of activated NK
cells that express NKG2C and ILT-2 but whose expression of
NKG2A, NKp30 and NKp46 is skewed.
To address the specific characterization of the NKR repertoire
from CHIKV-infected patients, hierarchical clustering analysis of
CD3
-CD56
+ NK cells was performed. In an important finding, it
showed that CHIKV-infected patients were easily distinguished
from both sets of healthy controls and expressed homogeneous
patterns of cell-surface markers (Figure 2B). This analysis did not
distinguish the Caucasian from the Gabonese healthy controls. In
addition, Spearman rank correlation analyses tested viral load
versus NKR expression, which was modulated on NK cells from
CHIKV-infected patients. They showed that only the expression
of NKG2A and NKG2C (both their frequency and MFI) was
significantly correlated with viral load (Figure 3A and Supple-
mentary Figure S2). It is noteworthy that kinetic studies of the
three viremic Caucasian CHIKV-infected patients, during the first
four months post-symptoms, demonstrated that the NKR
modulation was transient. Figure 3B shows that the overexpression
of ILT-2 and NKG2C and the down-modulation of NKG2A,
NKp30 and NKp46 were transient in all patients tested; the levels
of all of these NKRs returned nearly to baseline within two months
after symptoms stopped. Other markers, such as NKG2D, were
not modulated after infection and remained consistent over time
(Figure 3B). As noted above, the modulation of certain NKRs on
NK cells was closely linked to the viral load, which ranged from
4.3610
6 to 6.0610
7 copies/ml at the time of symptom onset and
became undetectable in all patients within two months (Supple-
mentary Table S1).
Preferential modulation of receptors for HLA-C1 alleles
on NK cells from CHIKV-infected patients
As previously shown, KIRs are stochastically expressed on the
surface of NK cells and are critical for monitoring alterations in
MHC expression during viral infection, as shown in the KIR gene
cluster in the NCBI dbLRC database (http://www.ashi-hla.org/
docs/pubs/abstracts/abs05/10.html). While acute CHIKV infec-
tion is associated with a high frequency of NK cells (Figure 1A), as
described [23], it is uncertain whether this expansion occurs
specifically in KIR-expressing NK cells. We therefore assessed the
overall change in KIR
+ NK cells with a pool of antibodies
combining CD158a, CD158b, CD158e, and NKB1, and observed
a similar frequency in both CHIKV-infected and healthy
individuals (data not shown). However, when KIR markers were
split during single KIR analysis, CHIKV-infected and control
individuals had significantly different levels of receptors for HLA-
C alleles. These included KIR2DL1, specific for HLA-C2 alleles,
and KIR2DL2/DL3, specific for HLA-C1 alleles. Profiles for both
frequency and MFI of inhibitory ligands for HLA-C molecules
were similar (Figure 4A and Supplementary Figure S3A). Thus,
compared with healthy controls, NK cells from CHIKV
+ patients
expressed significantly less KIR2DL1 (p=0.0027) and significantly
more KIR2DL2/DL3 (p=0.0008) (Figure 4A). Thus, up to 76%
of the NK cells in CHIKV-infected patients were stained with an
anti-KIR2DL2/DL3 mAb. Importantly, KIR2DL1 expression in
NK cells from CHIK-infected patients was significantly inversely
correlated with their KIR2DL2/DL3 expression (p=0.0318,
r=20.5201) (Supplementary Figure S3B). We therefore conduct-
ed several analyses to identify the underlying factors that might
account for these differences observed in KIR2DL1 and
KIR2DL2/DL3 expression during acute CHIKV infection.
Intriguingly, we observed significant correlations between these
receptors for HLA-C alleles and NKG2C: KIR2DL1 expression
was inversely correlated with NKG2C expression (r=20.5398,
p=0.0053), whereas KIR2DL2/DL3 expression was directly
correlated with it (r=0.7514, p,0.0001) (Figure 4B). These
findings were strengthened by significant correlations between
the viral load and expressions of both KIR2DL1 (r=20.2397,
p=0.0438) and KIR2DL2/DL3 (r=0.7110, p=0.0009)
(Figure 4C). Calculation of the MFI of inhibitory ligands for
HLA-C molecules produced similar profiles (Figure 4C). Expres-
sion levels of other inhibitory KIRs (KIR1DL4, KIR2DL5, and
KIR3DL1), and activating KIRs (KIR2DS1, KIR2DS2,
KIR2DS4, and KIR3DS1) were similar in all samples, irrespective
of viral load (Supplementary Figure S3C and data not shown).
Importantly, in the nine CHIKV-infected Gabonese patients who
had supplemental examinations, HLA-C genotyping revealed that
8 of them were HLA-C1/C1 or HLAC1/C2 (Table 1). Remark-
ably, the patients expressing the highest levels of KIR2DL2/DL3
on NK cells were those homozygous for HLA-CI/CI. Concom-
itantly, all of them expressed low levels of KIR2DL1, specifically
recognized by HLA-C2 alleles, in relation to high viral load and
NKG2C expression on NK cells (Table 1). It is important to note
that Table 1 also shows that all Caucasian CHIKV-infected
patients tested were HLA-C1/C1 or HLA-C1/C2, a genotype
associated with high expression of NKG2C and KIR2DL2/DL3
and low expression of KIR2DL1.
Effective cytotoxicity of NK cells from CHIKV-infected
patients
To evaluate the functional capacities of NK cells from CHIKV-
infected patients, non-activated and IL-2 activated PBMC were
analyzed in a degranulation assay against K562, 721.221, and
HLA-E-transfected 721.221 (AEH) target cells (Figure 5). In the
absence of IL-2 activation, a minimal level of CD107a expression
was detected at the surface of NK cells from healthy controls,
regardless of the target cell line. In contrast, the degranulation
capacity of NK cells from CHIKV-infected patients was strongly
enhanced against HLA-class I negative K562 (p=0.0005), and
13 combinations of NK cell markers from healthy controls (Caucasian, CAU and Gabonese, GAB), and CHIKV-infected individuals (CHIK). Each
horizontal line represents a particular NK-cell marker, and the color of each square reflects the percentage of cell-surface expression of the
corresponding marker in each healthy or CHIKV-infected sample. Values measured for all samples were color displayed and rank ordered with the
median for healthy donors considered the reference: green indicates below the median, and red indicates above the median, with values ranging
from -3 and +3. Analysis was performed with the Genesis program (available at www.genome.tugraz.at).
doi:10.1371/journal.ppat.1002268.g002
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PLoS Pathogens | www.plospathogens.org 5 September 2011 | Volume 7 | Issue 9 | e1002268Figure 3. Correlation between viral load and NKR expression and kinetic expression of NKRs after CHIKV infection. (A) Correlation
between viral load and NKG2A or NKG2C, both in frequency and MFI, on CD3
-CD56
+ NK cells from CHIKV-infected patients. NS: not significant. (B)
Three Caucasian CHIKV-infected patients were tested at 0, 2, and 4 months after symptom onset, to determine the frequency of various NKRs,
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PLoS Pathogens | www.plospathogens.org 6 September 2011 | Volume 7 | Issue 9 | e1002268Figure 4. Specific modulation of HLA-Cw ligands on CD3
-CD56
+ NK cells from CHIKV-infected patients. PBMC were collected from 15
Caucasian (CAU) and 15 Gabonese (GAB) healthy donors, and 25 CHIKV-infected patients (CHIK). (A) Frequency and MFI of KIR2DL1 and KIR2DL2/DL3
on CD3
-CD56
+ NK cells. Horizontal bars indicate the median. *: p,0.05; **: p,0.001. (B) Correlation between expression of NKG2C and HLA-Cw
ligands KIR2DL1 and KIR2DL2/DL3 on NK cells from the CHIKV-infected individuals. (C) Correlation between the viral load and KIR2DL1 or KIR2DL2/
DL3 on CD3
-CD56
+ NK cells, both in frequency and MFI.
doi:10.1371/journal.ppat.1002268.g004
Clonal Expansion of NK Cells in CHIKV Infection
PLoS Pathogens | www.plospathogens.org 7 September 2011 | Volume 7 | Issue 9 | e1002268721.221 (p=0.0008) target cells (Figures 5A and 5B). More
importantly, in the presence of HLA-E
+ target cells, NK cells from
CHIKV
+ patients displayed greater cytotoxic activity than did NK
cells from healthy donors (Figure 5C). These results are in
accordance with the high expression level of major activation
markers, including CD69, HLA-DR and NKp44, but also with
NKG2C, the receptor of HLA-E. The intracellular production of
perforin and granzyme-B did not differ between CHIKV-infected
and healthy individuals (data not shown). Following IL-2
activation, CD107a expression on NK cells from CHIKV
+
patients was similar to that in controls in the presence of K562
or 721.221 target cells. In contrast, in the presence of HLA-E
+
target cells, degranulation capacity was enhanced in NK cells from
CHIKV
+ patients, compared with those from controls (p=0.0414)
(Figures 5C and 5D). To confirm the key role of NKG2C in the
lytic capacity of NK cells from CHKIV
+ samples, we repeated
these experiments in the presence of neutralizing NKG2C mAb.
The degranulation capacity of NK cells from five CHIKV
+
patients decreased strongly in the presence of anti-NKG2C, to less
than 12.464.6%, compared with 44.665.4% in the presence of
an IgG isotypic control (Figure 5E).
Downmodulation of intracellular IFN-c expression in NK
cells from CHIKV-infected patients
In addition to their lytic activity, NK cells release several
cytokines and chemokines that play a role in the recruitment and
activation of the adaptive immune response [29]. The level of
intracellular IFN-c after treatment with IL-12 and IL-18 was
significantly lower in CHIKV
+ NK cells (p,0.0001) than among
the healthy controls, regardless of their geographic origin or race
(Figures 6A and 6B). These data are closely associated with the
inverse correlation between the production of IFN-c in the serum
of CHIKV-infected patients and the level of NKG2C expression
on NK cells (r=-0.8000; p=0.0002) (Figure 6C).
In summary, these results provide strong support for the
hypothesis that the expansion of NKG2C
+ NK cells from
CHIKV-infected individuals is associated with a dichotomy
between cytolytic and immunoregulatory functions in NK cells
during acute infection.
Discussion
This paper describes an extensive phenotypic and functional
study of NK cells from CHIKV-infected individuals and provides
the first evidence that CHIKV infection may selectively shape the
NKR repertoire of healthy individuals. NK cells in patients shortly
after CHIKV infection had significantly lower levels of NKp30
and NKp46, a reduction undoubtedly linked to their high
expression of activation markers (CD69 and HLA-DR), as
previously described after HCMV and HIV-1 infections [30–
32]. A hierarchical clustering analysis of a large panel of
phenotypic markers of the NK cell subset strengthened the
evidence of NKR repertoire modulation, showing that CHIKV-
infected patients, have phenotypes quite distinct from those of
either Caucasian or Gabonese healthy donors. This modulation
likely reflects the challenge exerted by CHIKV on the innate
immune system and thus may become a useful indicator for
exploring the complex host-pathogen relation during the acute
phase of infection.
In this study, we also demonstrated that CHIKV infection
appears to impair the ability of NK cells to produce IFN-c,a s
previously reported during such viral infections as HIV-1 and viral
hepatitis [30,33,34], particularly at the peak of viremia. This
impairment may be linked to the modulation in these patients of
the subset of cells that produce IFN-c most effectively — the
CD56
bright NK-cell subset. Experimental evidence indicates that
NK-cell development proceeds from a CD56
bright to CD56
dim
phenotype [35–37]. Several other changes in NKR expression
reinforce this concept that NK cells mature following CHIKV
infection. For example, expression of CD57, which has been
recognized as a marker of replicative senescence of T lymphocytes,
increases markedly on NK cells shortly after CHIKV infection.
This marker is known to be absent from cord blood NK cells and
found at higher levels in the elderly than in young or middle-aged
Table 1. Association between viral load, expression of NKG2C and KIR2DL2/DL3, and HLA-C1 genotype in CHIKV-infected patients.
Samples (#)
Viral Load (copies/
mL) Phenotype (%)* Genotype HLA-C
NKG2C KIR2DL1 KIR2DL2/DL3 Alleles Group
Gabonese patients
1 7.8 E04 25.6 16.9 25.2 0701/0401 C2/C1
2 2.5 E04 14.6 11.5 13.8 1403/0702 C2/C2
3 1.3 E05 19.9 8.8 32.4 1601/0402 C2/C1
5 8.4 E05 71.7 1.4 49.0 1402/0304 C1/C2
6 7.7 E03 25.0 25.3 35.4 1201/1802 C2/C1
12 7.4 E05 70.6 10.9 53.5 0602/1703 C1/C1
13 2.6 E06 56.3 11.9 62.5 0602/0302 C1/C2
18 3.3 E08 81.8 4.1 52.3 0705/1701 C1/C1
20 1.1 E06 71.8 5.9 65.2 0401/0202 C1/C1
Caucasian patients
1 2.3 E05 52.0 20.3 24.2 0101/0707 C1/C2
2 6.6 E06 55.7 14.8 37.3 0604/1301 C2/C1
3 5.1 E06 75.4 6.9 55.0 0302/0301 C1/C1
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PLoS Pathogens | www.plospathogens.org 9 September 2011 | Volume 7 | Issue 9 | e1002268subjects [38]. Consistent with these data, CHIKV infection
completely shifted the NK-cell repertoire to create a specific
subset of highly mature CD56
dim NK cells mostly unresponsive to
cytokine stimulation, but with strong cytolytic capacity for killing
diseased host cells, according to their cell-activation phenotype.
These data are in line with the recent study of Bjorkstro ¨m et al
[39] showing prompt NK cell activation and expansion in humans
infected with hantavirus.
Our data show that NKG2C
+ NK cells expand after CHIKC
infection. However we cannot exclude an induction of NKG2C
uponpreexistingNKcells,ortheelimination ofNKcellsthat donot
express NKG2C. This is closelyassociated with majormodifications
in the activation, differentiation, and cytolytic capacities of NK cells
from CHIKV-infected viremic individuals. NKG2 receptor expres-
sion switched from inhibitory to activating after acute CHIKV
infection, as previously described in other human infections,
including HIV-1, CMV, HBV, and HCV [40–42]. The loss of
NKG2A
+ NK cells accompanied the expansion of NKG2C
+ NK
cells, which exist at very low frequencies in uninfected individuals.
The frequency of NKG2C
+ cells observed among CHIKV-infected
individuals varied widely, but it is especially notable that it was
significantly correlated with viral load. Interestingly, the rapid
increasedofNKG2Cinresponseto the acute CHIKVinfectionwas
followed by a contraction phase, after viral clearance.
We cannot, however, reach a definitive conclusion about either
the expansion of a specific NK cell subset or a difference in the
lymphopenia rate in patients after CHIKV-infection, although
both have been observed in a restricted population of murine NK
cells expressing the activating receptor Ly49H
+ after MCMV
infection [43–45]. In this model, NK cells were shown to possess
features previously attributed to cells of the adaptive immune
system, including the expansion of a specific subset followed by
contraction and formation of cells with memory-like characteristics
[29,45,46]. NKG2C expression during acute hantavirus and HIV-
Figure 6. Significant down-modulation of intracellular IFN-c expression in NK cells from CHIKV-infected patients. (A) PBMC were
collected from 10 Caucasian (CAU), and 10 Gabonese (GAB) healthy donors, and 10 CHIKV-infected patients (CHIK) to determine intracellular
production of IFN-c after overnight treatment with IL-12 and IL-18. Horizontal bars indicate the median. ***: p,0.0001. (B) Representative samples of
each group are shown. Samples were gated on the CD3
-CD56
+ NK-cell gate for flow cytometric analysis. Numbers denote the percentage of
intracellular IFN-c
+ production among CD3
-CD56
+ NK cells. (C) Correlation between NKG2C expression by CD3
-CD56
+ NK cells and IFN-c production in
the sera of CHIKV-infected patients determined with Luminex Technology (Bio-Rad), as recently published [14].
doi:10.1371/journal.ppat.1002268.g006
Figure 5. Robust degranulation efficacy of NK cells from CHIKV-infected patients against HLA-E
+ target cells. PBMC were collected
from 10 Caucasian (CAU) and 10 Gabonese (GAB) healthy donors, and 10 CHIKV-infected patients (CHIK) to determine the cytolytic capacities of NK
cells, before and after a two-day treatment with IL-2. Degranulation activity was determined by CD107a expression against K562 (A), 721.221 (B), or
HLA-E-transfected 721.221 (AEH-cells) (C) target cells. Results are shown for an effector/target (E/T) cell ratio of 1/1. Horizontal bars indicate the
median. **: p,0.001. (D) Representative samples of each group were gated on the IL-2 activated CD3
-CD56
+ NK-cell subset in the presence of AEH
HLA-E-expressing target cells. Numbers denote the percentage of CD107a
+ cells among the CD3
-CD56
+ NK cells. (E) Neutralization of the
degranulation in the presence of anti-NKG2C mAb. PBMC from 5 healthy Caucasian (CAU) and 5 healthy Gabonese (GAB) donors, and 5 CHIKV-
infected patients (CHIK) were tested in the presence of neutralizing anti-NKG2C mAb (closed bars) or IgG isotypic control (Open bars) against HLA-E-
transfected 721.221. Results are expressed in mean6SD.
doi:10.1371/journal.ppat.1002268.g005
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seropositivity [31,39,47]. Here we found that NKG2C expression
was associated with HCMV serostatus in the three Caucasian
CHIKV-infected patients. Evaluation of the HCMV status of the
Gabonese patients was not relevant, as seroprevalence approaches
100% in this country [48].
More intriguingly, the NK cell repertoire appeared to be unusual
with strong and specific correlations between NKG2C expression
and specific self-inhibitory KIRs. In contrast to the overall NK cell
repertoire, which contains a random distribution of KIRs, the
NKG2C
+ NK cells in CHIKV-infected patients are associated with
HLA-Cw allele receptors. The correlation with KIR2DL1, recog-
nizing C2 HLA-C subtypes, is inverse, while that with KIR2DL2/
DL3, recognizing C1 subtypes, is direct. This suggests that NK cells
coexpressing NKG2C and receptors for HLA-C1 alleles expand
during an acute viral infection. More importantly, HLA-C
genotyping revealed that 11/12 CHIKV-infected patients exam-
inedindetailhadHLA-C1/C1orHLA-C1/C2alleles.Thisfinding
suggests that expansion of highly cytotoxic NKG2C
+ NK cells is
associated with imbalanced expression of unique self-specific
receptors and may dampen autoreactivity and limit immunopa-
thology in CHIKV-infected patients.
Analysis of a large number of CHIKV-infected individuals,
combining genetic analysis of KIR and HLA, kinetic study of
phenotypic and functional features of NK cells, and the long-term
evolution of clinical indicators, might make it possible to draw
statistically powerful conclusions. The presence of a single
inhibitory HLA-C binding KIR showed that the KIR overex-
pressed during CHIKV-infection mediates NK-cell licensing in the
highly functional NKG2C
+ NK cell subset, protecting against
autoreactivity. This finding is supported by our recent observation




+ [49]. These data are also
consistent with a case report of acute HCMV infection in a 3-
month-old girl whose genes encoded a deficient alpha-chain of the
IL-7 receptor known to be associated with a SCID-phenotype;
phenotype characterization showed an extreme transient ampli-
fication of NKG2C-bearing NK cells positive for KIR2DL2/DL3,
which accounted for more than 80% of the leukocytes [50]. More




+ NK cells in 5 hantavirus-
infected patients. Taken together, these important data suggest a
certain level of clonality in the response of NK cells against acute
infection, including CHIKV infection. However, the underlying
mechanism mediating this effect remains to be defined.
Collectively, our data suggest that the clonal expansion of a
unique subset of NK cells coexpressing NKG2C and receptors for
HLA-C1 alleles and correlated with the viral load, suggests that
NK cells are able to sense CHIKV from the beginning of infection
and may thus contribute to viral clearance. Understanding how
these complex innate responses affect the outcome of CHIKV
infection will help in the development of vaccines or other
therapeutic strategies that could use innate immunity to enhance
viral control with minimal pathogenesis.
Materials and Methods
Human ethics statement
This study was conducted in accordance with the principles
expressed in the Declaration of Helsinki and with French statutory
and regulatory law. Patients received information about research
performed on biological samples and provided written informed
consent to participate. The hospital’s institutional review board
(Comite ´ de protection des personnes Ile-de-France VI) approved
the study (Ho ˆpital Pitie ´-Salpe ˆtrie `re, 47 boulevard de l’Ho ˆpital,
75013 Paris).
Patients and healthy controls
Peripheral blood samples from 25 CHIKV-infected patients
(mean age 32615 years, 60% women) were obtained during the
CHIKV outbreak that occurred in Gabon, Central Africa,
between March and August 2007. The outbreak began first in
Libreville, the capital, and then spread to several small towns
located on the road towards Cameroon in northern Gabon,
generating approximately 20,000 cases. These samples were
collected from patients whose symptoms included fever, arthralgia,
and asthenia and who visited specific medical centers in Libreville
during the first five days after the onset of symptoms. Diagnosis of
CHIKV infection was confirmed for each of these patients, as
described [7,14]. These CHIKV-infected patients were negative
for dengue fever, yellow fever, West Nile fever, Rift Valley fever,
and malaria. Gabonese (n=15) and Caucasian (n=15) sex- and
age-matched healthy volunteers from Franceville (Gabon) and our
hospital blood bank (EFS, Pitie ´-Salpe ˆtrie `re Hospital, Paris, France)
were used as controls. Kinetic studies were performed on 3
Caucasian CHIKV-infected patients from the Department of
Infectious Diseases of the Pitie ´-Salpe ˆtrie `re Hospital (Paris, France)
in 2006.
Viral RNA extraction and quantification
Viral RNA was extracted from 90 ml of plasma from CHIKV-
infected patients with an EZ1 advanced XL system (Qiagen,
Courtaboeuf, France) and the EZ1 virus kit V2.0 (Qiagen). With
the high capacity cDNA reverse transcriptase kit (Applied
Biosystems, Foster City, CA, USA) and according to the manufac-
turer’s recommendations, 25 ml of extracted RNA was immedi-
ately reverse transcribed into cDNA. Real-time PCR was carried
out in a 7500 real-time PCR system (Applied Biosystems), with the
Universal PCR master mix kit (Applied Biosystems) according to
the manufacturer’s recommendations with the specific primers F-
CHIK and R-CHIK and the probe P-CHIK (10 mM) designed by
Pastorino et al. [51]. A quantified synthetic CHIKV RNA
transcript, kindly provided by the University of the Me ´diterrane ´e
(Pr X. De Lamballerie, Marseilles, France), was used as a standard.
All amplifications were performed in duplicate.
Flow cytometric analysis
NK cells were analyzed after staining with an appropriate
antibody cocktail: anti-CD45 (J33), anti-CD3-ECD (UCHT1),
anti-CD56-PC7 (N901), anti-CD8a-APC (B9.11), anti-CD159a/
NKG2A-APC (Z199), anti-CD336/NKp44-PE (Z231), anti-CD
335/NKp46-PE (BAB281), anti-NKG2D-PE (ON72), anti-CD
85j/ILT2-PE (HP-F1), anti-CD69-APC (FN50), and anti-HLA-
DR-PE (Immu357), KIR2DL1/KIR2DS1-PE (EB6B), anti-KIR
2DL2/KIR2DL3/KIR2DS2-PE (GL183), KIR3DL1/KIR3DS1-
PE (Z27) from Beckman Coulter; anti-CD94-FITC (HP-3D9),
anti-CD57-FITC (S-HCL-1), and anti-CD161-FITC (DX12) from
Becton Dickinson; anti-NKG2C-PE (134591), KIR2DS4-PE
(179315), and anti-KIR2DL4-APC (181703) from R&D systems;
anti-CD337/NKp30-PE (AF29-4D12), anti-KIR2DL1-APC (11
PB6), anti-KIR2DL2/KIR2DL3-APC (DX27), and anti-KIR
3DL1-APC (DX9) from Miltenyi Biotech; and anti-KIR2DL5-
Alexa Fluor 647 (UP-R1) from e-biosciences. For intracellular
staining, PBMC were fixed and permeabilized with a cytofix/
cytoperm kit (Becton Dickinson) and stained with perforin-PE
(dG9), or granzyme-B-FITC (GB1), as described [36]. Isotype-
matched immunoglobulins served as negative controls. Lympho-
cytes were identified by characteristic forward and side scatter
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gated on patterns of CD56/CD3 staining within the CD45
+
lymphocyte population. Results are expressed as the percentage of
positive cells within the gated population. At least 20,000 CD45
+
cells were analyzed on a Navios cytometer (Beckman Coulter).
Expression of each NKR was measured as a percentage of the
total CD3
-CD56
+ NK cells. Hierarchical clustering was applied,
and the results were displayed with the use of the Genesis program
(software available at www.genome.tugraz.at), as previously
described [52–54].
Functional analysis
Degranulation was assessed by the detection of LAMP1/
CD107a, on PBMC cultured in the absence or in the presence
of 1000 IU/ml of Proleukin-2 (Chiron) for 48 h, against K562,
721.211 or HLA-E-transfected 721.221 (AEH) target cell lines.
Briefly, PBMC were resuspended in the presence of anti-CD107a
mAb (H4A3, Becton Dickinson) with target cells at an effector:-
target (E:T) cell ratio of 1:1. After 1 h of incubation, monensin
(Sigma Aldrich) was added at 2 mM for an additional 4 h of
incubation [36,38].
To stimulate IFN-c production, PBMC were incubated
overnight in the presence of IL-12 (10 ng/ml) and IL-18
(100 ng/ml) (R&D Systems). Cells were then fixed and permea-
bilized with a cytofix/cytoperm kit (Becton Dickinson) and stained
with anti-IFN-c mAb (B27; Becton Dickinson), as described [36].
HLA-Cw typing
Genomic DNA was extracted from PBMC of CHIKV-infected
patients with the QIAmp DNA mini kit (Qiagen). HLA-C alleles
were sequenced with the SBT kit (Aria Genetics). Sequences were
read with a 3100 Genetic analyzer (Applied Biosystems) and
computer-assisted Conexio genomics software.
Statistical analysis
All statistical analyses were performed with Prism-5 software
(GraphPad Software). Intergroup comparisons were assessed with
the non-parametric Kruskal-Wallis test, with Dunn’s post test to
define the significance between results from 3 independent groups
of subjects. Significance was defined by P less than 0.05 with a 2-
tailed test. *p,0.05, **p,0.01, ***p,0.001. Nonparametric
correlations were assessed by determination of the Spearman’s
rank correlation coefficient.
Supporting Information
Figure S1 Cell-surface expression of NK cell markers
on NK cells from Caucasian (CAU) and Gabonese (GAB)
healthy donors, and CHIKV-infected patients (CHIK).
(A) PBMC from one representative sample of each group of
samples were stained with specific antibodies against NKG2A,
NKG2C, ILT-2, NKp30 and NKp46, and then gated on the
CD3
-CD56
+ NK-cell gate for flow cytometric analysis. Numbers
denote the percentage of positive cells in the CD3
-CD56
+ NK-cell
gate. (B) MFI of the expression of NK-cell receptors including
NKG2A, NKG2C, ILT-2, NKp30 and NKp46. Horizontal bars
indicate the median. *: p,0.05; **: p,0.001; ***: p,0.0001.
(TIF)
Figure S2 Expression of KIR in CHIKV-infected pa-
tients. (A) Expression of KIR2DL1 and KIR2DL2/DL3 on NK
cells from one representative sample of each group, including
Caucasian (CAU) and Gabonese (GAB) healthy donors, and
CHIKV-infected patient (CHIK). Numbers denote the percentage
of positive cells in the CD3
-CD56
+ NK-cell gate. (B) Correlation
between KIR2DL1 and KIR2DL2/DL3 expression on CD3
-
CD56
+ NK cells from CHIKV-infected patients. (C) Frequency
and MFI values of KIR2DL4, KIR2DL5, and KIR3DL1 on NK
cells from Caucasian (CAU), and Gabonese (GAB) healthy donors,
and CHIKV-infected patients (CHIK).
(TIF)
Figure S3 Expression of KIR in CHIKV-infected pa-
tients. (A) Expression of KIR2DL1 and KIR2DL2/DL3 on NK
cells from one representative sample of each group, including
Caucasian (CAU) and Gabonese (GAB) healthy donors, and
CHIKV-infected patient (CHIK). Numbers denote the percentage
of positive cells in the CD3
-CD56
+ NK-cell gate. (B) Correlation
between KIR2DL1 and KIR2DL2/DL3 expression on CD3
-
CD56
+ NK cells from CHIKV-infected patients. (C) Frequency
and MFI values of KIR2DL4, KIR2DL5, and KIR3DL1 on NK
cells from Caucasian (CAU), and Gabonese (GAB) healthy donors,
and CHIKV-infected patients (CHIK).
(TIF)
Table S1 Viral load, absolute count and frequency of
CD3
+ T and CD3
-CD56
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